Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets
Sign Up to like & getrecommendations! Published in 2019 at "Current Osteoporosis Reports"
DOI: 10.1007/s11914-019-00534-w
Abstract: Purpose of ReviewOsteosarcoma (OS) is the most common cancer of bone, yet is classified as a rare cancer. Treatment and outcomes for OS have not substantively changed in several decades. While the decoding of the… read more here.
Keywords: era preclinical; therapeutic targets; genome era; preclinical models ... See more keywords